Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Putting stem cells to the test

To truly know whether a stem cell has the developmental flexibility to give rise to new, therapeutic tissue types, the cells must undergo a definitive test in which they are injected into mice and observed. Yet many say this measure is too slow, too expensive and too unreliable. Elie Dolgin goes in search of a replacement.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

References

  1. Somers, A. et al. Stem Cells 28, 1728–1740 (2010).

    Article  CAS  Google Scholar 

  2. James, D., Noggle, S.A., Swigut, T. & Brivanlou, A.H. Dev. Biol. 295, 90–102 (2006).

    Article  CAS  Google Scholar 

  3. Müller, F.J., Goldmann, J., Löser, P. & Loring, J.F. Cell Stem Cell 6, 412–414 (2010).

    Article  Google Scholar 

  4. Müller, F.J. et al. Nature 455, 401–405 (2008).

    Article  Google Scholar 

  5. Baek, K.H. et al. Nature 459, 1126–1130 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Dolgin, E. Putting stem cells to the test. Nat Med 16, 1354–1357 (2010). https://doi.org/10.1038/nm1210-1354

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1210-1354

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer